Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Sildenafil and nasal obstruction.

Motamed M, Sandhu D, Murty GE.

J Otolaryngol. 2003 Aug;32(4):259-61.

PMID:
14587568
2.

Nasal obstruction as a common side-effect of sildenafil citrate.

Kiroglu AF, Bayrakli H, Yuca K, Cankaya H, Kiris M.

Tohoku J Exp Med. 2006 Mar;208(3):251-4.

3.

The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.

Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA.

J Am Coll Cardiol. 2002 Oct 2;40(7):1232-40.

5.

A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency.

Aydin E, Hizal E, Onay O, Ozgen B, Turhan B, Zaimoglu M, Peskircioglu L, Budakoglu II.

Am J Rhinol. 2008 May-Jun;22(3):276-9. doi: 10.2500/ajr.2008.22.3169.

PMID:
18588760
6.

Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.

Yuan Z, Hein TW, Rosa RH Jr, Kuo L.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):720-5. doi: 10.1167/iovs.07-1208.

PMID:
18235020
7.

Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.

Brenner S.

Neurology. 2006 May 9;66(9):1455-6; author reply 1455-6. No abstract available.

PMID:
16682690
8.

Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra): a randomized placebo-controlled study.

Trimarchi M, Salonia A, Bondi S, Montorsi F, Bussi M.

Eur Arch Otorhinolaryngol. 2008 Mar;265(3):303-6.

PMID:
17906871
9.

Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.

Pomara G, Morelli G, Pomara S, Taddei S, Ghiadoni L, Dinelli N, Travaglini F, Dicuio M, Mondaini N, Salvetti A, Selli C.

J Androl. 2004 Jul-Aug;25(4):625-9.

10.

Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.

Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ.

J Hypertens. 2008 Mar;26(3):501-7. doi: 10.1097/HJH.0b013e3282f382ff.

PMID:
18300861
11.

Oral sildenafil reduces pulmonary hypertension after cardiac surgery.

Trachte AL, Lobato EB, Urdaneta F, Hess PJ, Klodell CT, Martin TD, Staples ED, Beaver TM.

Ann Thorac Surg. 2005 Jan;79(1):194-7; discussion 194-7. Review.

PMID:
15620942
12.

Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.

Maharaj CH, O'Toole D, Lynch T, Carney J, Jarman J, Higgins BD, Morrison JJ, Laffey JG.

Reprod Biol Endocrinol. 2009 Apr 23;7:34. doi: 10.1186/1477-7827-7-34.

13.
14.

The effect of sildenafil on ocular blood flow.

Harris A, Kagemann L, Ehrlich R, Ehrlich Y, López CR, Purvin VA.

Br J Ophthalmol. 2008 Apr;92(4):469-73. doi: 10.1136/bjo.2007.131789. Review.

PMID:
18369062
16.

Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.

Jaillard S, Larrue B, Deruelle P, Delelis A, Rakza T, Butrous G, Storme L.

Ann Thorac Surg. 2006 Mar;81(3):935-42.

PMID:
16488698
17.

Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.

Guazzi M, Casali M, Berti F, Rossoni G, Colonna VD, Guazzi MD.

Clin Pharmacol Ther. 2008 Feb;83(2):336-41.

PMID:
17653139
18.

Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors.

Mauricio MD, Segarra G, Medina P, Aldasoro M, Martínez-León JB, Vila JM.

Eur J Pharmacol. 2006 Jan 20;530(3):259-62.

PMID:
16380114
20.

Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.

Afif-Abdo J, Teloken C, Damião R, Koff W, Wroclawski E, Yamasaki R, Torres LO, Sabaneeff J, Faria G, Pompeo AC, Cortado P, Glina S.

BJU Int. 2008 Sep;102(7):829-34. doi: 10.1111/j.1464-410X.2008.07767.x.

Supplemental Content

Support Center